Results
1 -
10 of
11Determination of Accurate Thermodynamics of Binding for Proteinase-Inhibitor Interactions, Molecular Modeling and Prediction of Bioactivity Structural and Energetic Aspects of Protein-Ligand Binding in Drug Design, Molecular Modeling and Prediction of Bioactivity Hepatobiliary transport of YM466, a novel factor Xa inhibitor, in rats, European Journal of Drug Metabolism and Pharmacokinetics Pharmacokinetics of an emerging new class of anticoagulant/antithrombotic drugs, European Journal of Clinical Pharmacology The effect of warfarin on the pharmacokinetics and pharmacodynamics of napsagatran in healthy male volunteers, European Journal of Clinical Pharmacology Thrombin inhibitors with novel P1 binding pocket functionality: free energy of binding analysis, Journal of Molecular Modeling A New Reversible and Potent P2Y12 Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial, Clinical Drug Investigation Napsagatran comparable to unfractionated heparin in DVT, Inpharma Weekly